Audience -All Patients & Families-Adults & Aging-Chapters-Donors & Supporters-Healthcare Providers-Kids & Young Adults-Men-Payers-Spanish Speaking Individuals-Undiagnosed-Women & Girls Type of Bleeding Disorder -All Bleeding Disorders-Hemophilia-Inhibitors-Rare Bleeding Disorders-Von Willebrand Disease Topic -Advocacy-Awareness-Blood & Product Safety-Bone & Joint Health-Community-COVID-19-Digital Health-Diversity, Equity & Inclusion-Fitness & Nutrition-Future Therapies-Health Equity-Healthcare Insurance-HIV & Hepatitis C-Mental Health-Pain Management-Sexual & Reproductive Health-Research-Treatment & Care 03 May Lentiviral Gene Therapy for Artemis-Deficient SCID May 3, 2023 - May 3, 2023 26 Apr Increasing Health Equity IQ Apr 26, 2023 - Apr 26, 2023 19 Apr 10 Things You Need to Know About Cannabis Apr 19, 2023 - Apr 19, 2023 12 Apr Raising the Bar for Joint Health Apr 12, 2023 - Apr 12, 2023 05 Apr Empowering the Community Through Knowledge and Resources Apr 5, 2023 - Apr 5, 2023 29 Mar National Research Blueprint: A Continued Conversation Mar 29, 2023 - Mar 29, 2023 22 Mar National Research Blueprint: An Introduction Mar 22, 2023 - Mar 22, 2023 15 Mar Global Perspectives on Prophylaxis Mar 15, 2023 - Mar 15, 2023 08 Mar Gene Therapy in Hemophilia: Educating the Community on the Science to Aid in Conversation with Your Healthcare Team Mar 8, 2023 - Mar 8, 2023 01 Mar Equitable Access to Behavioral Health Treatment for the Bleeding Disorders Community Mar 1, 2023 - Mar 1, 2023 22 Feb Fishing for answers to hemostatic and thrombotic disease: Genome editing in zebrafish Feb 22, 2023 - Feb 22, 2023 15 Feb Research Grant Recruitment Feb 15, 2023 - Feb 15, 2023 08 Feb Real-world study of rurioctocog alfa pegol and emicizumab in US clinical practice among patients with hemophilia A Feb 8, 2023 - Feb 8, 2023 01 Feb The Need for Menstrual Research Feb 1, 2023 - Feb 1, 2023 25 Jan Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia A Jan 25, 2023 - Jan 25, 2023 18 Jan inSourceRX Prescription Savings Jan 18, 2023 - Jan 18, 2023 11 Jan VWD Guidelines: Second Anniversary Update Jan 11, 2023 - Jan 11, 2023 14 Dec Efanesoctocog: A Truly Long-Acting FVIII Replacement Product Dec 14, 2022 - Dec 14, 2022 07 Dec Effects and Interferences of Emicizumab, a Humanised Bispecific Antibody Mimicking Activated Factor VIII Cofactor Function, on Coagulation Assays Dec 7, 2022 - Dec 7, 2022 30 Nov Giving Tuesday Highlight & The Importance of End-of-Year Giving Nov 30, 2022 - Nov 30, 2022 16 Nov VWD and Joint Bleeds Nov 16, 2022 - Nov 16, 2022 26 Oct Global seroprevalence of pre-existing immunity against AAV5 and other AAV serotypes in people with hemophilia A Oct 26, 2022 - Oct 26, 2022 19 Oct What's At Stake With The Upcoming Elections Oct 19, 2022 - Oct 19, 2022 12 Oct Genetic Counseling for Ultra-Rare Bleeding Disorders Oct 12, 2022 - Oct 12, 2022 Pagination First page Previous page Page 1 Page 2 Current page 3 Page 4 Page 5 Page 6 Page 7 Next page Last page
08 Mar Gene Therapy in Hemophilia: Educating the Community on the Science to Aid in Conversation with Your Healthcare Team Mar 8, 2023 - Mar 8, 2023
01 Mar Equitable Access to Behavioral Health Treatment for the Bleeding Disorders Community Mar 1, 2023 - Mar 1, 2023
22 Feb Fishing for answers to hemostatic and thrombotic disease: Genome editing in zebrafish Feb 22, 2023 - Feb 22, 2023
08 Feb Real-world study of rurioctocog alfa pegol and emicizumab in US clinical practice among patients with hemophilia A Feb 8, 2023 - Feb 8, 2023
25 Jan Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia A Jan 25, 2023 - Jan 25, 2023
07 Dec Effects and Interferences of Emicizumab, a Humanised Bispecific Antibody Mimicking Activated Factor VIII Cofactor Function, on Coagulation Assays Dec 7, 2022 - Dec 7, 2022
26 Oct Global seroprevalence of pre-existing immunity against AAV5 and other AAV serotypes in people with hemophilia A Oct 26, 2022 - Oct 26, 2022
